Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Analogue de nucléotide")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 569

  • Page / 23
Export

Selection :

  • and

α-Azido Bisphosphonates: Synthesis and Nucleotide AnaloguesCHAMBERLAIN, Brian T; UPTON, Thomas G; KASHEMIROV, Boris A et al.Journal of organic chemistry. 2011, Vol 76, Num 12, pp 5132-5136, issn 0022-3263, 5 p.Article

Nanoencapsulation of antiviral nucleotide analogsHILLAIREAU, H; COUVREUR, P.Journal of drug delivery science and technology. 2009, Vol 19, Num 6, pp 385-390, issn 1773-2247, 6 p.Article

Single-Dose Pharmacokinetics of Cidofovir in Continuous Venovenous HemofiltrationVOSSEN, Matthias G; GATTRINGER, Klaus-Bernhard; JÄGER, Walter et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 1952-1955, issn 0066-4804, 4 p.Article

The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosidesMAGEE, Wendy C; EVANS, David H.Antiviral research. 2012, Vol 96, Num 2, pp 169-180, issn 0166-3542, 12 p.Article

GS-9191 Is a Novel Topical Prodrug of the Nucleotide Analog 9-(2-Phosphonylmethoxyethyl)Guanine with Antiproliferative Activity and Possible Utility in the Treatment of Human Papillomavirus LesionsWOLFGANG, Grushenka H. I; SHIBATA, Riri; ANDREI, Graciela et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 2777-2784, issn 0066-4804, 8 p.Article

Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?JANSEN, Robert S; ROSING, Hilde; SCHELLENS, Jan Hm et al.Fundamental & clinical pharmacology. 2011, Vol 25, Num 2, pp 172-185, issn 0767-3981, 14 p.Article

Pre-Steady-State Kinetic Analysis of the Incorporation of Anti-HIV Nucleotide Analogs Catalyzed by Human X- and Y-Family DNA PolymerasesBROWN, Jessica A; PACK, Lindsey R; FOWLER, Jason D et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 1, pp 276-283, issn 0066-4804, 8 p.Article

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2NTEMGWA, Michel L; D'AQUIN TONI, Thomas; BRENNER, Bluma G et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 2, pp 708-715, issn 0066-4804, 8 p.Article

Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantationHELTON, K. J; PATAY, Z; TRIPLETT, B. M et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 5, pp 729-731, issn 0268-3369, 3 p.Article

Impact of choice of NRTI in first-line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovirBRENNAN, Alana T; SHEARER, Kate; MASKEW, Mhairi et al.TM & IH. Tropical medicine & international health. 2014, Vol 19, Num 5, pp 490-498, issn 1360-2276, 9 p.Article

Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infectionHEUFT, Merel M; HOUBA, Sanne M; VAN DEN BERK, Guido E. L et al.AIDS (London). 2014, Vol 28, Num 7, pp 999-1005, issn 0269-9370, 7 p.Article

Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCTDIROU, S; MALARD, F; MOHTY, M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 5, pp 622-627, issn 0268-3369, 6 p.Article

sofosbuvir(SOVALDI°): Actif sur le virus de l'hépatite C, mais une évaluation clinique incomplèteLa Revue Prescrire. 2014, Vol 34, Num 372, pp 726-732, issn 0247-7750, 7 p.Article

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV InfectionDEEKS, Emma D.Drugs (Basel). 2014, Vol 74, Num 17, pp 2079-2095, issn 0012-6667, 17 p.Article

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/ lamivudine + efavirenz administered on a multiple tablet therapyBLANCO, José L; MONTANER, Julio S. G; PERNO, Carlo F et al.AIDS (London). 2014, Vol 28, Num 17, pp 2531-2539, issn 0269-9370, 9 p.Article

Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALLUSSOWICZ, M; MUSIAL, J; DUSZENKO, E et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 5, pp 740-741, issn 0268-3369, 2 p.Article

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trialCHOOPANYA, Kachit; MARTIN, Michael; CHUACHOOWONG, Rutt et al.Lancet (British edition). 2013, Vol 381, Num 9883, pp 2083-2090, issn 0140-6736, 8 p.Article

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopeniaASSOUMOU, Lambert; KATLAMA, Christine; VIARD, Jean-Paul et al.AIDS (London). 2013, Vol 27, Num 15, pp 2425-2430, issn 0269-9370, 6 p.Article

Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning : Treatment and Hematopoietic Stem Cell Transplantation in Aplastic AnemiaMAURY, S; ALJURF, M.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 196-197, issn 0268-3369, 2 p.Article

Novel DNA polymerase mutations conferring cytomegalovirus resistance: Input of BAC-recombinant phenotyping and 3D modelHANTZ, Sébastien; COTIN, Sébastien; ALAIN, Sophie et al.Antiviral research. 2013, Vol 98, Num 1, pp 130-134, issn 0166-3542, 5 p.Article

Randomized Trial of the Virologic Response during up to Two Years of Entecavir-Adefovir Combination Therapy in Multiple-Drug-Refractory Chronic Hepatitis B Virus PatientsLIM, Young-Suk; LEE, Ji-Young; LEE, Danbi et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3369-3374, issn 0066-4804, 6 p.Article

Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug InteractionsKIS, Olena; ZASTRE, Jason A; TOZAMMEL HOQUE, Md et al.Pharmaceutical research. 2013, Vol 30, Num 4, pp 1050-1064, issn 0724-8741, 15 p.Article

Tenofovir Treatment Duration Predicts Proteinuria in a Multiethnic United States Cohort of Children and Adolescents With Perinatal HIV-1 InfectionPURSWANI, Murli; PATEL, Kunjal; KOPP, Jeffrey B et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 5, pp 495-500, issn 0891-3668, 6 p.Article

Tenofovir-based combination therapy for HIV/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemiaCHILDS, Kate; JOSHI, Deepak; BYRNE, Ruth et al.AIDS (London). 2013, Vol 27, Num 9, pp 1443-1448, issn 0269-9370, 6 p.Article

Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapyETIEBET, Mary-Ann A; SHEPHERD, James; EYZAGUIRRE, Lindsay M et al.AIDS (London). 2013, Vol 27, Num 4, pp 553-561, issn 0269-9370, 9 p.Article

  • Page / 23